I too have have previously been impressed by the technology and previous glossy investor presentations. I see nothing really changing in this newest carnation. New company name, (so the tarnished reputation of Tissue Therapies previous follies doesn't arise unfounded suspicions). I agree that there appears to be some progress being made and some clearer guidance as to the regulatory process, but my memory is quite good around previous guidance and deficiencies of this lot.
I am impressed that they have been able to secure additional funding through existing institutional and new sophisticated investors. I can't see myself averaging down at this stage, I'd need to invest too much and my risk aversion has increased since March last year.
Not convinced that there is little downside, there is still plenty of time and additional hurdles that need to be cleared with the new approach. I really hope I'm wrong, I'd love to be eating humble pie in 12 to 18 months time.
Good luck to all and happy decision making around this new request for your dosh.....
TIS Price at posting:
4.5¢ Sentiment: Hold Disclosure: Held
